World Intellectual Property Organization

Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highlights

Retrieved on: 
Tuesday, May 3, 2022
Board, Imipramine, COVID-19, Traumatic brain injury, Psilocybin, Population, Drug discovery, Placement, IND, PCT, Maintenance, Cannabidiol, Clinic, Failure, TBI, Company, Biotechnology, Depression, SVS, Fungus, Patient, Trial of the century, Review, Pharmacology, Cyclothymia, Risk, Clinical trial, Hierarchy, FDA, Human, GMP, Patent, CAD, MD, Psychotherapy, Phrase, Health, Lists of diseases, MDD, Mental health, OCD, News, Research, Central nervous system, Consultant, World Intellectual Property Organization, SEDAR, Security (finance), Medical device, Pharmaceutical industry, Hospital, Risk management, Esketamine

On March 22, 2022, Wesana delivered data from an animal study, conducted by an independent global laboratory services provider in a validated model of depression.

Key Points: 
  • On March 22, 2022, Wesana delivered data from an animal study, conducted by an independent global laboratory services provider in a validated model of depression.
  • The Company believes the written response provides a path to agreements on IND-enabling studies and validates the teams effort and accomplishments over the past year.
  • On January 18, 2022, Wesana shared positive results of an animal study on a novel depression treatment protocol.
  • Medical billings1 from Wesana Clinics increased 30% in the first quarter of 2022 as compared to the fourth quarter of 2021.

Gap Inc. Releases Its 2021 Environmental, Social, and Governance Report

Retrieved on: 
Thursday, April 21, 2022
Retail, Alternative Energy, Energy, Manufacturing, Other Consumer, Women, Online Retail, Environment, Men, Children, Agriculture, Natural Resources, Specialty, Textiles, Consumer, Fashion, Design, Social, Clothing, World's fair, Gap, Woman, Workplace, Water, Old Navy, Research, Invention, Collection, World Intellectual Property Organization, Silver Award, Silver Award (Girl Scouts of the USA), ESG, ESG Solutions, Gap Inc., Love, Electricity, Drinking water, Social Security Government Pension Offset, City, Biodiversity, Omnichannel, Man, Human rights, The Hong Kong Research Institute of Textiles and Apparel, WIPO, Industry, Inclusive, Lithium, Management, Athleta

In recognition of Earth Day, we are announcing the release of Gap Inc.s 2021 Environmental, Social and Governance (ESG) Report .

Key Points: 
  • In recognition of Earth Day, we are announcing the release of Gap Inc.s 2021 Environmental, Social and Governance (ESG) Report .
  • This report reflects the progress that the company and its brands, Old Navy, Gap, Banana Republic and Athleta, made in 2021 toward building a more sustainable and inclusive business.
  • Gap Inc. has aligned its ESG strategy to the pillars of Empowering Women and Human Rights, Enabling Opportunity, and Enriching Communities.
  • This report covers Gap Inc.s global operations for fiscal 2021, which ended on January 29, 2022, unless otherwise noted.

Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and Inhaled DMT

Retrieved on: 
Wednesday, April 13, 2022
Biotechnology, Mental Health, Health, Pharmaceutical, Clinical Trials, Patent, News, Inc., Inhalation, EDGAR, U.S. Securities and Exchange Commission, COVID-19, Risk, Research, Factor X, Anxiety, Food, NYSE American, World Intellectual Property Organization, Therapy, Regulation of tobacco by the U.S. Food and Drug Administration, Lists of diseases, Patient, Engineering, Goal, DMT, Growth, Psilocybin, Company, IV, Forward-looking statement, NYSE, Safety, Health Canada, Physician, Disease, View, NEO, Time, Pharmaceutical industry

Specifically, inhaled CYB004 demonstrated significant advantages over both IV DMT and inhaled DMT, including longer duration of action, and improved bioavailability.

Key Points: 
  • Specifically, inhaled CYB004 demonstrated significant advantages over both IV DMT and inhaled DMT, including longer duration of action, and improved bioavailability.
  • The study also demonstrated that inhaled CYB004 showed a similar onset of effect and dose profile to IV DMT.
  • In many studies, DMT has shown to be a promising and effective psychedelic for the treatment of mental health issues.
  • CYB004 via inhalation may solve these challenges and finally support a clinical path forward for this important therapeutic.

Cybin Announces Publication of International PCT Patent Application for Inhalation Delivery of Multiple Psychedelic Molecules

Retrieved on: 
Friday, April 8, 2022
Biotechnology, Mental Health, Alternative Medicine, Health, Pharmaceutical, Company, Therapy, Inhalation, DMT, Patent, Inc., Risk, Forward-looking statement, Growth, NYSE, PCT, Patient, Research, Lists of diseases, World Intellectual Property Organization, NEO, Food, View, NYSE American, Safety, U.S. Securities and Exchange Commission, Regulation of tobacco by the U.S. Food and Drug Administration, WIPO, Goal, Patent Cooperation Treaty, Time, COVID-19, Psilocybin, News, Engineering, EDGAR, Health Canada, Disease, IP, Pharmaceutical industry

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics, today announced that the World Intellectual Property Organization (WIPO) published an international patent application covering a range of inhalation delivery methods across multiple psychedelic molecules (Patent Cooperation Treaty (PCT) patent application no.PCT/EP2021/077057), further strengthening its long-term intellectual property (IP) position of psychedelic-based programs.

Key Points: 
  • Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics, today announced that the World Intellectual Property Organization (WIPO) published an international patent application covering a range of inhalation delivery methods across multiple psychedelic molecules (Patent Cooperation Treaty (PCT) patent application no.PCT/EP2021/077057), further strengthening its long-term intellectual property (IP) position of psychedelic-based programs.
  • The publication of this PCT patent application demonstrates our continued commitment to discovering and developing new psychedelic-based treatment options, in addition to identifying and combining potentially improved and well-controlled delivery systems with these clinical candidates, said Doug Drysdale, Chief Executive Officer of Cybin.
  • The PCT application titled Methods For Delivery Of Psychedelic Medications By Inhalation And Systems For Performing The Methods allows Cybin to pursue patent applications and seek protection for multiple inhaled forms of psychedelic molecules that are currently being researched and developed, or may be developed by the Company in the future.
  • Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, United Kingdom and Ireland.

Dogtown Media CEO Invited By United Nations World Intellectual Property Organization (WIPO) To Speak On Intellectual Property In Mobile And Web Applications

Retrieved on: 
Tuesday, March 22, 2022
ACT, Risk, First Nations in Ontario, Partnership, Association, Bangkok, Environment, Privacy, CEO, Government, Artificial intelligence, WIPO, Intellectual property, World Intellectual Property Organization, IOT, United Nations, Department, DIP, Lawyer, IP, Video game, Creative industries

This virtual round table to be hosted by The World Intellectual Property Organization (WIPO), supported by Marc Fischer, CEO and co-founder of Dogtown Media looks to answer that question.

Key Points: 
  • This virtual round table to be hosted by The World Intellectual Property Organization (WIPO), supported by Marc Fischer, CEO and co-founder of Dogtown Media looks to answer that question.
  • As a leader in mobile app development, Marc has ample experience earning how to navigate intellectual property when developing new technologies and bringing mobile digital products to market.
  • To address IP concerns, co-founder and CEO of Dogtown Media, Marc Fischer spoke at the event, "Intellectual Property in Mobile and Web Applications".
  • The World Intellectual Property Organization or WIPO is a global forum that addresses topics and policies related to intellectual property.

Enveric Biosciences Announces Publication of Four Patent Applications for Psychedelic-Inspired Drug Candidates

Retrieved on: 
Tuesday, March 15, 2022
Phrase, World Intellectual Property Organization, SEC, Anxiety, Immunomodulation, International, Annual report, Patent Cooperation Treaty, Review, Patient, Intention, Serotonin, Therapy, Budget, Psychiatry, Post-traumatic stress disorder, Psilocybin, Nature, COVID-19, DMT, Forward-looking statement, Patent, Security (finance), Brain, NASDAQ, Tryptamine, PTSD, Company, WIPO, Drug development, U.S. Securities and Exchange Commission, Lists of diseases, Meta-analysis, Coronavirus, PCT, Pharmaceutical industry, MD, Enver Pasha

Additional PCT patent applications are expected to publish over the coming months.

Key Points: 
  • Additional PCT patent applications are expected to publish over the coming months.
  • "These patent applications aim to protect Enveric's assets of new drug candidates and place our discovery engine at the forefront of bringing forward innovative psychiatric and neurologic therapeutics of the future."
  • 2021;12:739053. doi: 10.3389/fphar.2021.739053
    Enveric Biosciences (NASDAQ: ENVB) isa cutting-edge neuroscience company developing next-generation psychedelic-inspired mental health medicines.
  • Enveric disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Impact BioMedical’s Proprietary Equivir Compound to Treat Viral Infection Receives Clean Patentability Report from World Intellectual Property Organization’s ISA Division

Retrieved on: 
Thursday, March 3, 2022
Risk, United Nations, Myricetin, DSS, IPO, EIS, Infection, Leadership, EVD, Rhinovirus, SARS, Virus, ISA, World, Patent, Health, Quality of life, International, Invention, FDA, Solution, Growth, LLC, Epidemic Intelligence Service, NYSE, Patentability, Renewable energy, Biomedicine, Degenerative disease, WIPO, Polyphenol, EHF, Ebola, GRAS, Acquisition, CEO, World Intellectual Property Organization, Â, Intellectual property, R, USPTO, Drug discovery, World Health Organization, First Nations in Ontario, Human, GLOBE, Vaccine, 3D printing, Pharmaceutical industry

The receipt of this clean patentability report for Equivirs international patent application is demonstrative of our desire to make Impact Biomedicals antiviral innovations available to protect people worldwide, said Frank.

Key Points: 
  • The receipt of this clean patentability report for Equivirs international patent application is demonstrative of our desire to make Impact Biomedicals antiviral innovations available to protect people worldwide, said Frank.
  • Equivir is believed to block the entry of virus to host cells and thereby prevent infection and replication in host cells.
  • It is hoped that Equivir can be used as a deployable strategic defense for a broad spectrum of viral infections.
  • Impact BioMedical strives to leverage its scientific know-how and intellectual property rights to provide solutions that have been plaguing the biomedical field for decades.

Katten Lands Experienced Litigator and DEI Leader in New York

Retrieved on: 
Wednesday, March 2, 2022
Corporate law, Leadership, American Arbitration Association, Reed Smith, Industry, ICDR, Public relations, Government, Aviation, International Centre, AAA, American, JAMS, WIPO, DEI, Environment, Mass media, World Intellectual Property Organization, Court show, Intellectual property, Executive Committee, Transport, District court, Practice of law, Katten

His practice concentrates on complex commercial disputes, with a focus on disputes in the life sciences, financial services and media and entertainment sectors.

Key Points: 
  • His practice concentrates on complex commercial disputes, with a focus on disputes in the life sciences, financial services and media and entertainment sectors.
  • "At Katten, Geoff will have an opportunity to make a meaningful impact, strengthening our New York team."
  • Katten is a full-service law firm with approximately 700 attorneys in locations across the United States and in London and Shanghai.
  • Katten represents public and private companies in numerous industries, as well as a number of government and nonprofit organizations and individuals.

CCC’s Roy Kaufman Named to the Board of the United States Intellectual Property Alliance

Retrieved on: 
Thursday, January 27, 2022
Software, Technology, Other Professional Services, Professional Services, AT, Ecosystem, AT&T, MIT, Copyright Alliance, Intellectual property, Organization, Board, Recording Industry Association of America, IBM, Leadership, Knowledge, Industry, IP, RIAA, Information management, WIPO, Copyright Clearance Center, CCC, Software, Awareness, World Intellectual Property Organization, Business development, Quality of life, USPTO, Government, Management

CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, announces Roy Kaufman, Managing Director, Business Development and Government Relations, has been appointed to the Board of the United States Intellectual Property Alliance (USIPA).

Key Points: 
  • CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, announces Roy Kaufman, Managing Director, Business Development and Government Relations, has been appointed to the Board of the United States Intellectual Property Alliance (USIPA).
  • The USIPA Board features representatives of various organizations and constituencies that make up the Intellectual Property Ecosystem in the U.S., including the U.S. Patent & Trademark Office (USPTO), the World Intellectual Property Organization (WIPO), the Copyright Alliance, the Recording Industry Association of America (RIAA), AT&T, IBM, and MIT, among others.
  • The U.S. is recognized as a world-leading, collaborative ecosystem for intellectual property creation that fuels prosperity and improves the quality of life in our communities, said Kaufman.
  • A pioneer in voluntary collective licensing, Copyright Clearance Center (CCC) helps organizations integrate, access, and share information through licensing, content, software, and professional services.

Stratio, Inc. Partners With NIPA for All-New Advanced AI Vision System

Retrieved on: 
Wednesday, December 29, 2021
Technology, Mobile, Wireless, Homeland Security, Security, Other Technology, Public Policy, Government, Audio, Video, Software, Data Management, Machine learning, Software, NIPA, IP, AI, Database, Algorithm, World Intellectual Property Organization, CEO, WIPO, Intellectual property, National IT Industry Promotion Agency, National, Technology, Time, Cloud computing, SWIR, 3D printing, Mobile phone, Stration, Stratio, Inc., NIPA, STRATIO, INC., NIPA

According to the World Intellectual Property Organization (WIPO), over 1.3 million applications for new industrial designs were filed globally in 2020.

Key Points: 
  • According to the World Intellectual Property Organization (WIPO), over 1.3 million applications for new industrial designs were filed globally in 2020.
  • Similar registered designs are then presented, each with a similarity score generated using the apps AI.
  • To learn more about the upcoming BeyonSense SWIR camera, please visit beyonsense.io and to learn about NIPA, please visit nipa.kr/eng/index.do.
  • Stratio, Inc. is an AI and sensor company designing and creating portable infrared solutions as part of its mission to bring infrared vision to the mass market.